Becton Dickinson invests $50m in Columbus expansion:
This article was originally published in Clinica
Becton Dickinson is to inject $50m into its Columbus, Ohio operations, adding two new manufacturing lines for prefilled syringes in response to growing demand BD told Clinica. The expansion, which also includes a new sterilisation building, will create 75 new jobs over the next 18 months. The company expects to complete one production line by early 2005 and the second in 2006.
You may also be interested in...
The race is now on to get formal adoption of European Commission proposal postponing the MDR by one year and allowing more devices on the market more quickly. But potential hurdles are in the way as experts advise caution.
Australia’s competition regulator, the ACCC, has granted a conditional dispensation to allow generics industry association the GBMA and brand body Medicines Australia to work together to help address the coronavirus pandemic by sharing information on stock, inventory, manufacturing and the supply chain. However, tender pricing will not be among the subjects discussed.